Annual Income Statements for MetLife
This table shows MetLife's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.
Quarterly Income Statements for MetLife
This table shows MetLife's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.
| Metric |
|
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
Q1 2025 |
Q2 2025 |
Q3 2025 |
Q4 2025 |
Q1 2026 |
| Net Income / (Loss) Attributable to Common Shareholders |
|
422 |
574 |
800 |
912 |
1,275 |
1,239 |
879 |
698 |
818 |
778 |
1,140 |
| Consolidated Net Income / (Loss) |
|
495 |
614 |
875 |
953 |
1,341 |
1,275 |
950 |
735 |
902 |
816 |
1,162 |
| Net Income / (Loss) Continuing Operations |
|
495 |
614 |
875 |
953 |
1,341 |
1,275 |
950 |
735 |
902 |
816 |
1,162 |
| Total Pre-Tax Income |
|
534 |
941 |
1,045 |
1,202 |
1,994 |
1,381 |
1,354 |
980 |
1,210 |
1,117 |
1,507 |
| Total Revenue |
|
15,866 |
20,210 |
16,751 |
17,823 |
17,909 |
19,612 |
18,270 |
17,617 |
17,361 |
24,045 |
18,954 |
| Net Interest Income / (Expense) |
|
0.00 |
- |
0.00 |
0.00 |
0.00 |
- |
0.00 |
0.00 |
0.00 |
- |
0.00 |
| Total Interest Income |
|
0.00 |
- |
0.00 |
0.00 |
0.00 |
- |
0.00 |
0.00 |
0.00 |
- |
0.00 |
| Total Interest Expense |
|
0.00 |
- |
0.00 |
0.00 |
0.00 |
- |
0.00 |
0.00 |
0.00 |
- |
0.00 |
| Total Non-Interest Income |
|
15,866 |
20,210 |
16,751 |
17,823 |
17,909 |
19,612 |
18,270 |
17,617 |
17,361 |
24,045 |
18,954 |
| Other Service Charges |
|
1,940 |
1,901 |
1,922 |
1,919 |
1,876 |
1,858 |
1,916 |
1,938 |
1,971 |
2,005 |
2,195 |
| Net Realized & Unrealized Capital Gains on Investments |
|
2,696 |
5,341 |
4,082 |
4,276 |
5,917 |
4,191 |
4,930 |
4,592 |
4,835 |
5,118 |
4,759 |
| Premiums Earned |
|
11,230 |
11,786 |
10,053 |
11,628 |
10,647 |
12,617 |
11,723 |
10,810 |
10,555 |
16,691 |
12,120 |
| Other Non-Interest Income |
|
- |
- |
694 |
- |
-531 |
- |
-299 |
277 |
- |
- |
-120 |
| Total Non-Interest Expense |
|
15,332 |
19,269 |
15,706 |
16,621 |
15,915 |
18,231 |
16,916 |
16,637 |
16,151 |
22,928 |
17,447 |
| Property & Liability Insurance Claims |
|
12,771 |
14,217 |
12,364 |
13,475 |
12,634 |
14,594 |
13,453 |
13,167 |
12,771 |
19,308 |
13,538 |
| Insurance Policy Acquisition Costs |
|
153 |
159 |
147 |
148 |
150 |
150 |
144 |
146 |
134 |
129 |
124 |
| Other Operating Expenses |
|
3,204 |
3,280 |
3,195 |
3,180 |
3,131 |
3,305 |
3,319 |
3,324 |
3,509 |
3,527 |
3,785 |
| Income Tax Expense |
|
39 |
327 |
170 |
249 |
653 |
106 |
404 |
245 |
308 |
301 |
345 |
| Preferred Stock Dividends Declared |
|
67 |
33 |
67 |
34 |
67 |
32 |
66 |
31 |
78 |
31 |
45 |
| Net Income / (Loss) Attributable to Noncontrolling Interest |
|
6.00 |
7.00 |
8.00 |
7.00 |
-1.00 |
4.00 |
5.00 |
6.00 |
6.00 |
7.00 |
-23 |
| Basic Earnings per Share |
|
$0.56 |
$0.76 |
$1.11 |
$1.28 |
$1.82 |
$1.77 |
$1.29 |
$1.04 |
$1.23 |
$1.18 |
$1.75 |
| Weighted Average Basic Shares Outstanding |
|
740.19M |
723.02M |
711.12M |
700.32M |
692.42M |
681.23M |
671.30M |
665.03M |
658.89M |
652.05M |
643.44M |
| Diluted Earnings per Share |
|
$0.56 |
$0.75 |
$1.10 |
$1.28 |
$1.81 |
$1.75 |
$1.28 |
$1.03 |
$1.22 |
$1.18 |
$1.74 |
| Weighted Average Diluted Shares Outstanding |
|
740.19M |
723.02M |
711.12M |
700.32M |
692.42M |
681.23M |
671.30M |
665.03M |
658.89M |
652.05M |
643.44M |
| Weighted Average Basic & Diluted Shares Outstanding |
|
740.19M |
723.02M |
711.12M |
700.32M |
692.42M |
681.23M |
671.30M |
665.03M |
658.89M |
652.05M |
643.44M |
| Cash Dividends to Common per Share |
|
$0.52 |
- |
$0.52 |
- |
- |
- |
$0.55 |
- |
- |
- |
$0.57 |
Annual Cash Flow Statements for MetLife
This table details how cash moves in and out of MetLife's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.
| Metric |
|
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
2025 |
| Net Change in Cash & Equivalents |
|
1,944 |
5,125 |
-5,176 |
3,120 |
777 |
3,962 |
-444 |
79 |
444 |
-571 |
1,964 |
| Net Cash From Operating Activities |
|
14,052 |
14,774 |
12,283 |
11,738 |
13,786 |
11,639 |
12,347 |
13,044 |
13,721 |
14,598 |
17,092 |
| Net Cash From Continuing Operating Activities |
|
14,052 |
14,774 |
12,283 |
11,738 |
13,786 |
11,639 |
12,347 |
13,044 |
13,721 |
14,598 |
17,092 |
| Net Income / (Loss) Continuing Operations |
|
5,385 |
854 |
4,020 |
5,128 |
5,909 |
5,418 |
6,876 |
5,302 |
1,602 |
4,444 |
3,403 |
| Consolidated Net Income / (Loss) |
|
5,385 |
854 |
4,020 |
5,128 |
5,909 |
5,418 |
6,876 |
5,302 |
1,602 |
4,444 |
3,403 |
| Depreciation Expense |
|
693 |
652 |
795 |
628 |
630 |
619 |
694 |
673 |
718 |
714 |
753 |
| Amortization Expense |
|
-1,141 |
-1,110 |
-1,044 |
-1,013 |
-999 |
-816 |
-874 |
-992 |
-1,332 |
-1,512 |
-1,840 |
| Non-Cash Adjustments to Reconcile Net Income |
|
-2,511 |
6,545 |
2,903 |
-1,209 |
821 |
1,565 |
1,321 |
2,615 |
10,627 |
8,804 |
9,161 |
| Changes in Operating Assets and Liabilities, net |
|
11,626 |
7,833 |
5,609 |
8,204 |
7,425 |
4,853 |
4,330 |
5,446 |
2,106 |
2,148 |
5,615 |
| Net Cash From Investing Activities |
|
-10,398 |
-5,850 |
-16,876 |
-5,634 |
-17,586 |
-18,569 |
-11,187 |
-2,620 |
-10,246 |
-11,493 |
-15,607 |
| Net Cash From Continuing Investing Activities |
|
-10,398 |
-5,850 |
-16,876 |
-5,634 |
-17,586 |
-18,569 |
-11,187 |
-2,620 |
-10,246 |
-11,493 |
-15,607 |
| Acquisitions |
|
-4,211 |
-6,963 |
-8,696 |
-4,173 |
-3,749 |
-4,247 |
-7,990 |
-7,793 |
-5,662 |
-3,981 |
-4,497 |
| Purchase of Investment Securities |
|
-173,918 |
-170,240 |
-124,533 |
-125,288 |
-108,884 |
-123,132 |
-141,348 |
-116,549 |
-89,164 |
-88,213 |
-106,433 |
| Sale and/or Maturity of Investments |
|
165,977 |
167,244 |
111,872 |
119,709 |
92,700 |
104,139 |
131,663 |
117,394 |
82,514 |
79,848 |
92,433 |
| Other Investing Activities, net |
|
1,754 |
3,953 |
4,481 |
4,118 |
2,347 |
4,671 |
3,218 |
3,738 |
2,066 |
853 |
2,890 |
| Net Cash From Financing Activities |
|
-1,218 |
-3,497 |
-906 |
-2,801 |
4,568 |
10,729 |
-1,126 |
-9,948 |
-2,940 |
-3,131 |
163 |
| Net Cash From Continuing Financing Activities |
|
-1,218 |
-3,497 |
-906 |
-2,801 |
4,568 |
10,729 |
-1,126 |
-9,948 |
-2,940 |
-3,131 |
163 |
| Issuance of Debt |
|
5,437 |
-3,636 |
4,560 |
224 |
3,526 |
4,812 |
1,912 |
-9,717 |
-612 |
1,609 |
2,157 |
| Repayment of Debt |
|
-96,116 |
-84,610 |
-89,197 |
-90,814 |
-86,571 |
-85,498 |
-93,791 |
-98,726 |
-92,835 |
-97,749 |
-104,256 |
| Repurchase of Preferred Equity |
|
-1,502 |
- |
- |
0.00 |
0.00 |
-1,003 |
-500 |
- |
0.00 |
0.00 |
-1,000 |
| Repurchase of Common Equity |
|
-1,930 |
-372 |
-2,927 |
-3,992 |
-2,285 |
-1,151 |
-4,303 |
-3,326 |
-3,103 |
-3,207 |
-2,883 |
| Payment of Dividends |
|
-1,769 |
-1,839 |
-1,820 |
-1,819 |
-1,821 |
-1,859 |
-1,842 |
-1,783 |
-1,764 |
-1,727 |
-1,703 |
| Other Financing Activities, Net |
|
93,179 |
86,960 |
88,478 |
92,326 |
91,719 |
93,467 |
97,398 |
103,604 |
95,374 |
97,943 |
107,848 |
| Effect of Exchange Rate Changes |
|
-492 |
-302 |
- |
-183 |
9.00 |
163 |
-478 |
-397 |
-91 |
-545 |
316 |
| Cash Interest Paid |
|
1,178 |
1,202 |
1,118 |
1,130 |
964 |
891 |
914 |
905 |
989 |
1,037 |
1,041 |
| Cash Income Taxes Paid |
|
1,127 |
672 |
1,530 |
1,935 |
1,099 |
787 |
1,102 |
1,056 |
1,833 |
1,600 |
1,564 |
Quarterly Cash Flow Statements for MetLife
This table details how cash moves in and out of MetLife's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.
| Metric |
|
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
Q1 2025 |
Q2 2025 |
Q3 2025 |
Q4 2025 |
Q1 2026 |
| Net Change in Cash & Equivalents |
|
-3,980 |
14,266 |
-3,127 |
-2,544 |
-3,190 |
8,290 |
-3,004 |
-1,335 |
-5,512 |
11,815 |
-2,032 |
| Net Cash From Operating Activities |
|
3,475 |
5,182 |
2,328 |
3,490 |
4,169 |
4,611 |
4,262 |
2,187 |
3,567 |
7,076 |
2,687 |
| Net Cash From Continuing Operating Activities |
|
- |
13,721 |
0.00 |
- |
- |
14,598 |
0.00 |
- |
- |
17,092 |
0.00 |
| Net Income / (Loss) Continuing Operations |
|
- |
1,602 |
0.00 |
- |
- |
4,444 |
0.00 |
- |
- |
3,403 |
0.00 |
| Net Cash From Investing Activities |
|
-2,972 |
576 |
-2,627 |
-1,340 |
-2,162 |
-5,364 |
-3,322 |
-2,981 |
-5,018 |
-4,286 |
-5,455 |
| Net Cash From Continuing Investing Activities |
|
-2,972 |
576 |
-2,627 |
-1,340 |
-2,162 |
-5,364 |
-3,322 |
-2,981 |
-5,018 |
-4,286 |
-5,455 |
| Acquisitions |
|
-1,474 |
-1,446 |
-1,052 |
-1,209 |
-522 |
-1,198 |
-1,013 |
-946 |
-1,205 |
-1,333 |
-1,458 |
| Purchase of Investment Securities |
|
-22,075 |
-17,084 |
-19,739 |
-22,704 |
-21,965 |
-23,805 |
-25,279 |
-23,023 |
-27,235 |
-30,896 |
-32,566 |
| Sale and/or Maturity of Investments |
|
20,007 |
17,923 |
17,941 |
22,268 |
19,585 |
20,054 |
21,710 |
20,253 |
22,802 |
27,668 |
28,391 |
| Other Investing Activities, net |
|
570 |
1,183 |
223 |
305 |
740 |
-415 |
1,260 |
735 |
620 |
275 |
178 |
| Net Cash From Financing Activities |
|
-848 |
-176 |
-261 |
-1,205 |
-1,146 |
-519 |
220 |
1,449 |
-508 |
-998 |
3,559 |
| Net Cash From Continuing Financing Activities |
|
-848 |
-176 |
-261 |
-1,205 |
-1,146 |
-519 |
220 |
1,449 |
-508 |
-998 |
3,559 |
| Issuance of Debt |
|
111 |
-28 |
850 |
897 |
-447 |
309 |
1,388 |
541 |
75 |
153 |
2,244 |
| Repayment of Debt |
|
-21,915 |
-20,184 |
-23,845 |
-26,462 |
-24,455 |
-22,987 |
-27,739 |
-25,198 |
-25,776 |
-25,543 |
-24,741 |
| Repurchase of Common Equity |
|
-792 |
-859 |
-1,172 |
-855 |
-774 |
-406 |
-1,411 |
-510 |
-502 |
-460 |
-755 |
| Payment of Dividends |
|
-459 |
-419 |
-444 |
-423 |
-450 |
-410 |
-440 |
-413 |
-444 |
-406 |
-417 |
| Other Financing Activities, Net |
|
22,207 |
21,314 |
24,350 |
25,638 |
24,980 |
22,975 |
28,422 |
27,029 |
27,139 |
25,258 |
27,228 |
| Effect of Exchange Rate Changes |
|
-160 |
145 |
-239 |
1.00 |
118 |
-425 |
98 |
197 |
14 |
7.00 |
-136 |
| Cash Interest Paid |
|
206 |
311 |
231 |
296 |
223 |
287 |
224 |
283 |
247 |
287 |
243 |
| Cash Income Taxes Paid |
|
236 |
481 |
130 |
864 |
279 |
327 |
147 |
783 |
308 |
326 |
231 |
Annual Balance Sheets for MetLife
This table presents MetLife's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.
| Metric |
|
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
2025 |
| Total Assets |
|
877,933 |
898,764 |
719,892 |
687,538 |
740,463 |
795,146 |
759,708 |
663,072 |
687,584 |
677,457 |
745,166 |
| Cash and Due from Banks |
|
12,752 |
12,651 |
12,701 |
15,821 |
16,598 |
19,795 |
20,047 |
20,195 |
20,639 |
20,068 |
22,032 |
| Trading Account Securities |
|
369,747 |
306,380 |
328,189 |
312,321 |
342,264 |
354,809 |
353,685 |
288,132 |
292,500 |
292,427 |
330,748 |
| Loans and Leases, Net of Allowance |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Accrued Investment Income |
|
3,988 |
3,308 |
3,524 |
3,582 |
3,523 |
17,786 |
3,185 |
3,446 |
3,589 |
3,489 |
3,719 |
| Mortgage Servicing Rights |
|
67,102 |
65,167 |
68,731 |
75,752 |
80,529 |
83,919 |
79,353 |
83,763 |
92,506 |
89,012 |
84,593 |
| Unearned Premiums Asset |
|
22,702 |
15,445 |
18,423 |
19,644 |
20,443 |
17,870 |
17,149 |
17,364 |
28,971 |
29,761 |
49,059 |
| Deferred Acquisition Cost |
|
24,130 |
17,590 |
18,419 |
18,895 |
17,833 |
16,389 |
16,061 |
19,653 |
20,151 |
19,627 |
21,107 |
| Separate Account Business Assets |
|
301,598 |
195,578 |
205,001 |
175,556 |
188,445 |
199,970 |
179,873 |
146,038 |
144,634 |
139,504 |
151,933 |
| Goodwill |
|
9,477 |
9,220 |
9,590 |
9,422 |
9,308 |
10,112 |
9,535 |
9,297 |
9,236 |
8,901 |
9,613 |
| Other Assets |
|
66,437 |
273,425 |
55,314 |
56,545 |
61,520 |
74,496 |
80,820 |
75,184 |
75,358 |
74,668 |
72,362 |
| Total Liabilities & Shareholders' Equity |
|
877,933 |
898,764 |
719,892 |
687,538 |
740,463 |
795,146 |
759,708 |
663,072 |
687,584 |
677,457 |
745,166 |
| Total Liabilities |
|
809,437 |
831,062 |
661,022 |
634,580 |
674,081 |
720,329 |
691,959 |
632,947 |
657,331 |
649,754 |
716,245 |
| Short-Term Debt |
|
36,971 |
26,115 |
26,511 |
25,503 |
40,809 |
29,997 |
32,261 |
35,759 |
17,643 |
32,679 |
31,937 |
| Long-Term Debt |
|
25,356 |
20,884 |
19,951 |
17,036 |
4,143 |
18,601 |
17,855 |
3,874 |
19,346 |
3,640 |
5,713 |
| Future Policy Benefits |
|
191,879 |
166,636 |
177,974 |
186,780 |
194,909 |
206,656 |
199,721 |
187,222 |
196,406 |
193,646 |
208,855 |
| Participating Policy Holder Equity |
|
219,480 |
188,515 |
200,836 |
201,327 |
212,499 |
225,833 |
223,384 |
229,408 |
219,655 |
240,729 |
257,283 |
| Separate Account Business Liabilities |
|
301,598 |
195,578 |
205,001 |
175,556 |
188,445 |
199,970 |
179,873 |
146,038 |
144,634 |
139,504 |
151,933 |
| Other Long-Term Liabilities |
|
34,153 |
233,334 |
30,749 |
28,378 |
33,276 |
39,272 |
38,865 |
30,646 |
59,647 |
39,556 |
60,524 |
| Commitments & Contingencies |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Redeemable Noncontrolling Interest |
|
77 |
- |
- |
- |
- |
- |
- |
- |
- |
0.00 |
241 |
| Total Equity & Noncontrolling Interests |
|
68,419 |
67,702 |
58,870 |
52,958 |
66,382 |
74,817 |
67,749 |
30,125 |
30,253 |
27,703 |
28,680 |
| Total Preferred & Common Equity |
|
67,949 |
67,531 |
58,676 |
52,741 |
66,144 |
74,558 |
67,482 |
29,881 |
30,015 |
27,445 |
28,398 |
| Preferred Stock |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Total Common Equity |
|
67,949 |
67,531 |
58,676 |
52,741 |
66,144 |
74,558 |
67,482 |
29,881 |
30,015 |
27,445 |
28,398 |
| Common Stock |
|
30,761 |
30,956 |
31,123 |
32,486 |
32,692 |
33,824 |
33,523 |
33,628 |
33,702 |
33,803 |
32,870 |
| Retained Earnings |
|
35,519 |
34,683 |
26,527 |
28,926 |
33,078 |
36,491 |
41,197 |
40,332 |
40,146 |
42,626 |
44,290 |
| Treasury Stock |
|
-3,102 |
-3,474 |
-6,401 |
-10,393 |
-12,678 |
-13,829 |
-18,157 |
-21,458 |
-24,591 |
-27,798 |
-30,678 |
| Accumulated Other Comprehensive Income / (Loss) |
|
4,771 |
5,366 |
7,427 |
1,722 |
13,052 |
18,072 |
10,919 |
-22,621 |
-19,242 |
-21,186 |
-18,084 |
| Noncontrolling Interest |
|
470 |
171 |
194 |
217 |
238 |
259 |
267 |
244 |
238 |
258 |
282 |
Quarterly Balance Sheets for MetLife
This table presents MetLife's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.
| Metric |
|
Q2 2023 |
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
Q1 2025 |
Q2 2025 |
Q3 2025 |
Q1 2026 |
| Total Assets |
|
677,279 |
652,120 |
687,584 |
677,576 |
675,745 |
704,976 |
677,457 |
688,316 |
702,470 |
719,726 |
743,211 |
| Cash and Due from Banks |
|
15,417 |
14,912 |
20,639 |
19,840 |
20,786 |
21,765 |
20,068 |
21,326 |
22,178 |
20,233 |
22,687 |
| Trading Account Securities |
|
294,830 |
281,404 |
292,500 |
289,472 |
288,596 |
293,779 |
292,427 |
303,207 |
311,221 |
317,703 |
330,472 |
| Loans and Leases, Net of Allowance |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Accrued Investment Income |
|
3,505 |
3,704 |
3,589 |
3,636 |
3,657 |
13,757 |
3,489 |
3,557 |
3,532 |
3,791 |
3,796 |
| Mortgage Servicing Rights |
|
92,986 |
92,230 |
92,506 |
91,458 |
89,802 |
90,415 |
89,012 |
87,908 |
86,868 |
85,843 |
83,726 |
| Unearned Premiums Asset |
|
18,530 |
19,002 |
28,971 |
29,986 |
31,820 |
31,443 |
29,761 |
31,251 |
31,503 |
40,329 |
50,335 |
| Deferred Acquisition Cost |
|
19,850 |
19,737 |
20,151 |
19,842 |
19,568 |
20,401 |
19,627 |
20,162 |
20,993 |
21,175 |
21,269 |
| Separate Account Business Assets |
|
145,946 |
135,624 |
144,634 |
141,003 |
139,707 |
148,809 |
139,504 |
138,143 |
143,175 |
146,344 |
147,686 |
| Goodwill |
|
9,261 |
9,109 |
9,236 |
9,037 |
8,950 |
9,155 |
8,901 |
9,036 |
9,142 |
9,095 |
9,565 |
| Other Assets |
|
76,954 |
76,398 |
75,358 |
73,302 |
72,859 |
75,452 |
74,668 |
73,726 |
73,858 |
75,213 |
73,675 |
| Total Liabilities & Shareholders' Equity |
|
677,279 |
652,120 |
687,584 |
677,576 |
675,745 |
704,976 |
677,457 |
688,316 |
702,470 |
719,726 |
743,211 |
| Total Liabilities |
|
646,787 |
626,225 |
657,331 |
648,780 |
648,205 |
673,812 |
649,754 |
660,561 |
674,543 |
690,535 |
715,410 |
| Short-Term Debt |
|
33,545 |
33,492 |
17,643 |
33,569 |
18,109 |
17,536 |
32,679 |
17,821 |
32,900 |
32,817 |
33,006 |
| Long-Term Debt |
|
3,835 |
3,811 |
19,346 |
3,752 |
18,527 |
18,970 |
3,640 |
19,311 |
4,591 |
4,552 |
6,580 |
| Future Policy Benefits |
|
190,474 |
181,755 |
196,406 |
191,013 |
190,993 |
201,340 |
193,646 |
197,667 |
198,965 |
199,169 |
206,628 |
| Participating Policy Holder Equity |
|
234,421 |
233,979 |
219,655 |
239,744 |
239,287 |
244,922 |
240,729 |
225,979 |
252,699 |
256,042 |
240,173 |
| Separate Account Business Liabilities |
|
145,946 |
135,624 |
144,634 |
141,003 |
139,707 |
148,809 |
139,504 |
138,143 |
143,175 |
146,344 |
147,686 |
| Other Long-Term Liabilities |
|
38,566 |
37,564 |
59,647 |
39,699 |
41,582 |
42,235 |
39,556 |
61,640 |
42,213 |
51,611 |
81,337 |
| Commitments & Contingencies |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Redeemable Noncontrolling Interest |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
206 |
| Total Equity & Noncontrolling Interests |
|
30,492 |
25,895 |
30,253 |
28,796 |
27,540 |
31,164 |
27,703 |
27,755 |
27,927 |
29,191 |
27,595 |
| Total Preferred & Common Equity |
|
30,261 |
25,658 |
30,015 |
28,535 |
27,252 |
30,885 |
27,445 |
27,493 |
27,685 |
28,944 |
27,324 |
| Preferred Stock |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Total Common Equity |
|
30,261 |
25,658 |
30,015 |
28,535 |
27,252 |
30,885 |
27,445 |
27,493 |
27,685 |
28,944 |
27,324 |
| Common Stock |
|
33,642 |
33,678 |
33,702 |
33,730 |
33,752 |
33,778 |
33,803 |
33,832 |
33,834 |
32,867 |
32,933 |
| Retained Earnings |
|
39,928 |
39,958 |
40,146 |
40,350 |
40,873 |
41,765 |
42,626 |
43,131 |
43,447 |
43,887 |
45,058 |
| Treasury Stock |
|
-22,923 |
-23,724 |
-24,591 |
-25,774 |
-26,637 |
-27,418 |
-27,798 |
-29,222 |
-29,737 |
-30,244 |
-31,440 |
| Accumulated Other Comprehensive Income / (Loss) |
|
-20,386 |
-24,254 |
-19,242 |
-19,771 |
-20,736 |
-17,240 |
-21,186 |
-20,248 |
-19,859 |
-17,566 |
-19,227 |
| Noncontrolling Interest |
|
231 |
237 |
238 |
261 |
288 |
279 |
258 |
262 |
242 |
247 |
271 |
Annual Metrics And Ratios for MetLife
This table displays calculated financial ratios and metrics derived from MetLife's official financial filings.
| Metric |
|
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
2025 |
| DEI Shares Outstanding |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
658,891,656.00 |
| DEI Adjusted Shares Outstanding |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
658,891,656.00 |
| DEI Earnings Per Adjusted Shares Outstanding |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
5.16 |
| Growth Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Profitability Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Valuation Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Leverage & Solvency |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Liquidity Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Cash Flow Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Efficiency Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Capital & Investment Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Earnings Adjustments |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Adjusted Basic Earnings per Share |
|
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$6.10 |
$5.72 |
$7.36 |
$2.93 |
$1.82 |
$5.98 |
$4.74 |
| Adjusted Weighted Average Basic Shares Outstanding |
|
0.00 |
0.00 |
0.00 |
0.00 |
915.83M |
884.40M |
825.08M |
774.36M |
723.02M |
681.23M |
652.05M |
| Adjusted Diluted Earnings per Share |
|
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$6.06 |
$5.68 |
$7.31 |
$2.91 |
$1.81 |
$5.94 |
$4.71 |
| Adjusted Weighted Average Diluted Shares Outstanding |
|
0.00 |
0.00 |
0.00 |
0.00 |
915.83M |
884.40M |
825.08M |
774.36M |
723.02M |
681.23M |
652.05M |
| Adjusted Basic & Diluted Earnings per Share |
|
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Adjusted Weighted Average Basic & Diluted Shares Outstanding |
|
0.00 |
0.00 |
0.00 |
0.00 |
915.83M |
884.40M |
825.08M |
774.36M |
723.02M |
681.23M |
652.05M |
| Debt Service Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Payout Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Quarterly Metrics And Ratios for MetLife
This table displays calculated financial ratios and metrics derived from MetLife's official financial filings.
| Metric |
|
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
Q1 2025 |
Q2 2025 |
Q3 2025 |
Q4 2025 |
Q1 2026 |
| DEI Shares Outstanding |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
658,891,656.00 |
652,053,867.00 |
| DEI Adjusted Shares Outstanding |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
658,891,656.00 |
652,053,867.00 |
| DEI Earnings Per Adjusted Shares Outstanding |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
1.24 |
1.78 |
| Growth Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Revenue Growth |
|
-28.80% |
13.27% |
10.20% |
7.22% |
12.88% |
-2.96% |
10.85% |
-1.16% |
-3.06% |
- |
3.74% |
| EBITDA Growth |
|
-62.26% |
-53.55% |
306.61% |
179.53% |
273.41% |
46.76% |
29.57% |
-18.47% |
-39.32% |
- |
11.30% |
| EBIT Growth |
|
-62.26% |
-53.55% |
306.61% |
179.53% |
273.41% |
46.76% |
29.57% |
-18.47% |
-39.32% |
- |
11.30% |
| NOPAT Growth |
|
-57.58% |
-61.16% |
929.41% |
133.58% |
170.91% |
107.65% |
8.57% |
-22.88% |
-32.74% |
- |
22.32% |
| Net Income Growth |
|
-57.58% |
-61.16% |
929.41% |
133.58% |
170.91% |
107.65% |
8.57% |
-22.88% |
-32.74% |
- |
22.32% |
| EPS Growth |
|
-59.12% |
-61.73% |
5,400.00% |
166.67% |
223.21% |
133.33% |
16.36% |
-19.53% |
-32.60% |
- |
35.94% |
| Operating Cash Flow Growth |
|
-19.37% |
125.21% |
14.91% |
14.88% |
19.97% |
-11.02% |
83.08% |
-37.34% |
-14.44% |
- |
-36.95% |
| Free Cash Flow Firm Growth |
|
-88.12% |
-93.70% |
-82.17% |
-59.55% |
-151.27% |
43.61% |
-61.73% |
-110.91% |
164.26% |
- |
-161.38% |
| Invested Capital Growth |
|
-8.16% |
-3.61% |
-6.80% |
-5.45% |
7.08% |
-4.79% |
-1.86% |
1.94% |
-1.64% |
- |
3.85% |
| Revenue Q/Q Growth |
|
-4.55% |
27.38% |
-13.72% |
6.40% |
0.48% |
9.51% |
-5.32% |
-5.13% |
-1.45% |
- |
-21.17% |
| EBITDA Q/Q Growth |
|
24.19% |
76.22% |
11.05% |
15.02% |
65.89% |
-30.74% |
-1.96% |
-27.62% |
23.47% |
- |
34.92% |
| EBIT Q/Q Growth |
|
24.19% |
76.22% |
11.05% |
15.02% |
65.89% |
-30.74% |
-1.96% |
-27.62% |
23.47% |
- |
34.92% |
| NOPAT Q/Q Growth |
|
21.32% |
24.04% |
42.51% |
8.91% |
40.71% |
-4.92% |
-25.49% |
-22.63% |
22.72% |
- |
42.40% |
| Net Income Q/Q Growth |
|
21.32% |
24.04% |
42.51% |
8.91% |
40.71% |
-4.92% |
-25.49% |
-22.63% |
22.72% |
- |
42.40% |
| EPS Q/Q Growth |
|
16.67% |
33.93% |
46.67% |
16.36% |
41.41% |
-3.31% |
-26.86% |
-19.53% |
18.45% |
- |
47.46% |
| Operating Cash Flow Q/Q Growth |
|
14.38% |
49.12% |
-55.08% |
49.91% |
19.46% |
10.60% |
-7.57% |
-48.69% |
63.10% |
- |
-62.03% |
| Free Cash Flow Firm Q/Q Growth |
|
-46.86% |
-48.75% |
82.01% |
-18.40% |
-167.35% |
243.56% |
-51.50% |
-123.26% |
496.84% |
- |
22.79% |
| Invested Capital Q/Q Growth |
|
-6.89% |
6.40% |
-1.67% |
-2.94% |
5.44% |
-5.39% |
1.35% |
0.82% |
1.75% |
- |
1.23% |
| Profitability Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| EBITDA Margin |
|
3.37% |
4.66% |
6.24% |
6.74% |
11.13% |
7.04% |
7.29% |
5.56% |
6.97% |
- |
7.95% |
| EBIT Margin |
|
3.37% |
4.66% |
6.24% |
6.74% |
11.13% |
7.04% |
7.29% |
5.56% |
6.97% |
- |
7.95% |
| Profit (Net Income) Margin |
|
3.12% |
3.04% |
5.22% |
5.35% |
7.49% |
6.50% |
5.12% |
4.17% |
5.20% |
- |
6.13% |
| Tax Burden Percent |
|
92.70% |
65.25% |
83.73% |
79.28% |
67.25% |
92.32% |
70.16% |
75.00% |
74.55% |
- |
77.11% |
| Interest Burden Percent |
|
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
- |
100.00% |
| Effective Tax Rate |
|
7.30% |
34.75% |
16.27% |
20.72% |
32.75% |
7.68% |
29.84% |
25.00% |
25.45% |
- |
22.89% |
| Return on Invested Capital (ROIC) |
|
3.10% |
3.01% |
5.29% |
5.72% |
8.32% |
7.14% |
5.77% |
4.75% |
5.66% |
- |
7.26% |
| ROIC Less NNEP Spread (ROIC-NNEP) |
|
3.10% |
3.01% |
5.29% |
5.72% |
8.32% |
7.14% |
5.77% |
4.75% |
5.66% |
- |
7.26% |
| Return on Net Nonoperating Assets (RNNOA) |
|
4.88% |
3.82% |
6.56% |
7.30% |
10.76% |
9.03% |
7.60% |
6.34% |
6.93% |
- |
10.02% |
| Return on Equity (ROE) |
|
7.98% |
6.83% |
11.85% |
13.02% |
19.08% |
16.17% |
13.37% |
11.09% |
12.60% |
- |
17.28% |
| Cash Return on Invested Capital (CROIC) |
|
12.39% |
6.01% |
10.53% |
10.05% |
-1.05% |
11.68% |
8.78% |
4.72% |
7.41% |
- |
1.69% |
| Operating Return on Assets (OROA) |
|
0.34% |
0.47% |
0.64% |
0.70% |
1.19% |
0.74% |
0.79% |
0.60% |
0.72% |
- |
0.87% |
| Return on Assets (ROA) |
|
0.31% |
0.31% |
0.54% |
0.56% |
0.80% |
0.69% |
0.55% |
0.45% |
0.53% |
- |
0.67% |
| Return on Common Equity (ROCE) |
|
7.91% |
6.78% |
11.76% |
12.90% |
18.91% |
16.04% |
13.25% |
10.98% |
12.49% |
- |
17.05% |
| Return on Equity Simple (ROE_SIMPLE) |
|
10.01% |
0.00% |
8.38% |
10.78% |
12.25% |
0.00% |
16.44% |
15.54% |
13.34% |
- |
13.23% |
| Net Operating Profit after Tax (NOPAT) |
|
495 |
614 |
875 |
953 |
1,341 |
1,275 |
950 |
735 |
902 |
- |
1,162 |
| NOPAT Margin |
|
3.12% |
3.04% |
5.22% |
5.35% |
7.49% |
6.50% |
5.12% |
4.17% |
5.20% |
- |
6.13% |
| Net Nonoperating Expense Percent (NNEP) |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
- |
0.00% |
| SG&A Expenses to Revenue |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
- |
0.00% |
| Operating Expenses to Revenue |
|
96.63% |
95.34% |
93.76% |
93.26% |
88.87% |
92.96% |
92.71% |
94.44% |
93.03% |
- |
92.05% |
| Earnings before Interest and Taxes (EBIT) |
|
534 |
941 |
1,045 |
1,202 |
1,994 |
1,381 |
1,354 |
980 |
1,210 |
- |
1,507 |
| Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA) |
|
534 |
941 |
1,045 |
1,202 |
1,994 |
1,381 |
1,354 |
980 |
1,210 |
- |
1,507 |
| Valuation Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Price to Book Value (P/BV) |
|
1.79 |
1.57 |
1.89 |
1.82 |
1.87 |
2.05 |
1.99 |
1.94 |
1.88 |
- |
1.69 |
| Price to Tangible Book Value (P/TBV) |
|
2.77 |
2.27 |
2.77 |
2.71 |
2.66 |
3.04 |
2.96 |
2.89 |
2.74 |
- |
2.60 |
| Price to Revenue (P/Rev) |
|
0.70 |
0.69 |
0.78 |
0.70 |
0.79 |
0.78 |
0.74 |
0.73 |
0.74 |
- |
0.59 |
| Price to Earnings (P/E) |
|
19.45 |
34.18 |
24.93 |
18.28 |
16.22 |
13.33 |
12.71 |
13.10 |
14.97 |
- |
13.43 |
| Dividend Yield |
|
3.35% |
3.23% |
2.85% |
3.02% |
2.58% |
2.65% |
2.72% |
2.76% |
2.72% |
- |
3.21% |
| Earnings Yield |
|
5.14% |
2.93% |
4.01% |
5.47% |
6.16% |
7.50% |
7.87% |
7.64% |
6.68% |
- |
7.45% |
| Enterprise Value to Invested Capital (EV/IC) |
|
1.08 |
0.95 |
1.09 |
1.02 |
1.08 |
1.14 |
1.09 |
1.06 |
1.08 |
- |
0.94 |
| Enterprise Value to Revenue (EV/Rev) |
|
1.04 |
0.94 |
1.03 |
0.93 |
1.00 |
1.01 |
0.96 |
0.94 |
0.98 |
- |
0.81 |
| Enterprise Value to EBITDA (EV/EBITDA) |
|
21.07 |
41.19 |
24.32 |
17.64 |
14.05 |
15.10 |
11.93 |
12.11 |
14.57 |
- |
13.19 |
| Enterprise Value to EBIT (EV/EBIT) |
|
21.07 |
29.49 |
24.32 |
17.64 |
14.05 |
12.96 |
11.93 |
12.11 |
14.57 |
- |
13.19 |
| Enterprise Value to NOPAT (EV/NOPAT) |
|
26.64 |
39.80 |
29.99 |
22.35 |
19.24 |
16.39 |
15.66 |
16.07 |
18.58 |
- |
17.56 |
| Enterprise Value to Operating Cash Flow (EV/OCF) |
|
6.31 |
4.65 |
5.12 |
4.54 |
4.80 |
4.99 |
4.28 |
4.54 |
4.91 |
- |
4.09 |
| Enterprise Value to Free Cash Flow (EV/FCFF) |
|
8.36 |
15.48 |
9.94 |
9.90 |
0.00 |
9.50 |
12.31 |
22.60 |
14.43 |
- |
56.94 |
| Leverage & Solvency |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Debt to Equity |
|
1.44 |
1.22 |
1.30 |
1.33 |
1.17 |
1.31 |
1.34 |
1.34 |
1.28 |
- |
1.42 |
| Long-Term Debt to Equity |
|
0.15 |
0.64 |
0.13 |
0.67 |
0.61 |
0.13 |
0.70 |
0.16 |
0.16 |
- |
0.24 |
| Financial Leverage |
|
1.58 |
1.27 |
1.24 |
1.28 |
1.29 |
1.26 |
1.32 |
1.34 |
1.22 |
- |
1.38 |
| Leverage Ratio |
|
25.42 |
22.37 |
22.08 |
23.32 |
23.78 |
23.55 |
24.15 |
24.85 |
23.61 |
- |
25.77 |
| Compound Leverage Factor |
|
25.42 |
22.37 |
22.08 |
23.32 |
23.78 |
23.55 |
24.15 |
24.85 |
23.61 |
- |
25.77 |
| Debt to Total Capital |
|
59.03% |
55.01% |
56.45% |
57.09% |
53.95% |
56.73% |
57.23% |
57.31% |
56.14% |
- |
58.74% |
| Short-Term Debt to Total Capital |
|
53.00% |
26.24% |
50.77% |
28.22% |
25.91% |
51.04% |
27.46% |
50.29% |
49.30% |
- |
48.98% |
| Long-Term Debt to Total Capital |
|
6.03% |
28.77% |
5.67% |
28.87% |
28.03% |
5.69% |
29.76% |
7.02% |
6.84% |
- |
9.76% |
| Preferred Equity to Total Capital |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
- |
0.00% |
| Noncontrolling Interests to Total Capital |
|
0.38% |
0.35% |
0.39% |
0.45% |
0.41% |
0.40% |
0.40% |
0.37% |
0.37% |
- |
0.71% |
| Common Equity to Total Capital |
|
40.60% |
44.64% |
43.16% |
42.46% |
45.64% |
42.87% |
42.37% |
42.32% |
43.49% |
- |
40.55% |
| Debt to EBITDA |
|
11.49 |
23.89 |
12.65 |
9.84 |
7.04 |
7.53 |
6.26 |
6.57 |
7.59 |
- |
8.22 |
| Net Debt to EBITDA |
|
6.90 |
10.56 |
5.93 |
4.26 |
2.84 |
3.37 |
2.67 |
2.68 |
3.48 |
- |
3.51 |
| Long-Term Debt to EBITDA |
|
1.17 |
12.50 |
1.27 |
4.98 |
3.66 |
0.75 |
3.26 |
0.80 |
0.92 |
- |
1.37 |
| Debt to NOPAT |
|
14.52 |
23.09 |
15.60 |
12.47 |
9.65 |
8.17 |
8.22 |
8.72 |
9.68 |
- |
10.95 |
| Net Debt to NOPAT |
|
8.72 |
10.21 |
7.31 |
5.40 |
3.90 |
3.66 |
3.50 |
3.56 |
4.44 |
- |
4.67 |
| Long-Term Debt to NOPAT |
|
1.48 |
12.08 |
1.57 |
6.31 |
5.01 |
0.82 |
4.27 |
1.07 |
1.18 |
- |
1.82 |
| Noncontrolling Interest Sharing Ratio |
|
0.96% |
0.80% |
0.80% |
0.89% |
0.90% |
0.86% |
0.92% |
0.96% |
0.87% |
- |
1.33% |
| Liquidity Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Cash Flow Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Free Cash Flow to Firm (FCFF) |
|
6,107 |
3,130 |
5,697 |
4,649 |
-3,131 |
4,495 |
2,180 |
-507 |
2,012 |
- |
-1,338 |
| Operating Cash Flow to CapEx |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
- |
0.00% |
| Free Cash Flow to Firm to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
- |
0.00 |
| Operating Cash Flow to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
- |
0.00 |
| Operating Cash Flow Less CapEx to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
- |
0.00 |
| Efficiency Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Asset Turnover |
|
0.10 |
0.10 |
0.10 |
0.10 |
0.11 |
0.11 |
0.11 |
0.11 |
0.10 |
- |
0.11 |
| Fixed Asset Turnover |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
- |
0.00 |
| Capital & Investment Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Invested Capital |
|
63,198 |
67,242 |
66,117 |
64,176 |
67,670 |
64,022 |
64,887 |
65,418 |
66,560 |
- |
67,387 |
| Invested Capital Turnover |
|
0.99 |
0.99 |
1.01 |
1.07 |
1.11 |
1.10 |
1.13 |
1.14 |
1.09 |
- |
1.18 |
| Increase / (Decrease) in Invested Capital |
|
-5,612 |
-2,516 |
-4,822 |
-3,696 |
4,472 |
-3,220 |
-1,230 |
1,242 |
-1,110 |
- |
2,500 |
| Enterprise Value (EV) |
|
68,428 |
63,755 |
71,737 |
65,651 |
72,783 |
72,843 |
70,764 |
69,131 |
71,769 |
- |
63,489 |
| Market Capitalization |
|
45,800 |
47,167 |
53,995 |
49,513 |
57,763 |
56,334 |
54,696 |
53,576 |
54,386 |
- |
46,113 |
| Book Value per Share |
|
$34.12 |
$40.55 |
$40.13 |
$38.32 |
$44.10 |
$39.64 |
$40.36 |
$41.24 |
$43.52 |
- |
$41.90 |
| Tangible Book Value per Share |
|
$22.01 |
$28.07 |
$27.42 |
$25.74 |
$31.03 |
$26.78 |
$27.09 |
$27.62 |
$29.85 |
- |
$27.24 |
| Total Capital |
|
63,198 |
67,242 |
66,117 |
64,176 |
67,670 |
64,022 |
64,887 |
65,418 |
66,560 |
- |
67,387 |
| Total Debt |
|
37,303 |
36,989 |
37,321 |
36,636 |
36,506 |
36,319 |
37,132 |
37,491 |
37,369 |
- |
39,586 |
| Total Long-Term Debt |
|
3,811 |
19,346 |
3,752 |
18,527 |
18,970 |
3,640 |
19,311 |
4,591 |
4,552 |
- |
6,580 |
| Net Debt |
|
22,391 |
16,350 |
17,481 |
15,850 |
14,741 |
16,251 |
15,806 |
15,313 |
17,136 |
- |
16,899 |
| Capital Expenditures (CapEx) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
- |
0.00 |
| Net Nonoperating Expense (NNE) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
- |
0.00 |
| Net Nonoperating Obligations (NNO) |
|
37,303 |
36,989 |
37,321 |
36,636 |
36,506 |
36,319 |
37,132 |
37,491 |
37,369 |
- |
39,586 |
| Total Depreciation and Amortization (D&A) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
- |
0.00 |
| Earnings Adjustments |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Adjusted Basic Earnings per Share |
|
$0.56 |
$0.76 |
$1.11 |
$1.28 |
$1.82 |
$1.77 |
$1.29 |
$1.04 |
$1.23 |
$1.18 |
$1.75 |
| Adjusted Weighted Average Basic Shares Outstanding |
|
740.19M |
723.02M |
711.12M |
700.32M |
692.42M |
681.23M |
671.30M |
665.03M |
658.89M |
652.05M |
643.44M |
| Adjusted Diluted Earnings per Share |
|
$0.56 |
$0.75 |
$1.10 |
$1.28 |
$1.81 |
$1.75 |
$1.28 |
$1.03 |
$1.22 |
$1.18 |
$1.74 |
| Adjusted Weighted Average Diluted Shares Outstanding |
|
740.19M |
723.02M |
711.12M |
700.32M |
692.42M |
681.23M |
671.30M |
665.03M |
658.89M |
652.05M |
643.44M |
| Adjusted Basic & Diluted Earnings per Share |
|
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Adjusted Weighted Average Basic & Diluted Shares Outstanding |
|
740.19M |
723.02M |
711.12M |
700.32M |
692.42M |
681.23M |
671.30M |
665.03M |
658.89M |
652.05M |
643.44M |
| Normalized Net Operating Profit after Tax (NOPAT) |
|
-243 |
614 |
875 |
809 |
1,341 |
1,275 |
1,160 |
735 |
706 |
- |
1,162 |
| Normalized NOPAT Margin |
|
-1.53% |
3.04% |
5.22% |
4.54% |
7.49% |
6.50% |
6.25% |
4.17% |
4.07% |
- |
6.13% |
| Pre Tax Income Margin |
|
3.37% |
4.66% |
6.24% |
6.74% |
11.13% |
7.04% |
7.29% |
5.56% |
6.97% |
- |
7.95% |
| Debt Service Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| EBIT to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
- |
0.00 |
| NOPAT to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
- |
0.00 |
| EBIT Less CapEx to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
- |
0.00 |
| NOPAT Less CapEx to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
- |
0.00 |
| Payout Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Dividend Payout Ratio |
|
68.78% |
110.11% |
73.29% |
59.41% |
45.89% |
38.86% |
38.13% |
39.83% |
44.20% |
- |
46.47% |
| Augmented Payout Ratio |
|
179.33% |
303.81% |
219.40% |
184.64% |
142.64% |
111.03% |
114.38% |
111.93% |
117.45% |
- |
108.08% |
Key Financial Trends
MetLife’s latest quarter shows a mixed picture: solid balance-sheet scale and positive operating cash flow, but noticeably weaker earnings and cash generation than the prior quarter and the same period last year. In Q1 2026, MetLife earned $1.14 billion attributable to common shareholders, down from $778 million in Q4 2025 on a reported basis? Actually, the key comparison is that Q1 2026 profit remains positive, but both revenue and cash flow softened versus late 2025. The company continues to operate with a very large investment portfolio and substantial equity, but leverage remains elevated and operating performance has become more volatile quarter to quarter.
- Net income remained positive in Q1 2026. MetLife reported $1.16 billion in consolidated net income and $1.14 billion attributable to common shareholders, showing the business is still profitable even in a weaker quarter.
- Operating cash flow stayed positive. MetLife generated $2.69 billion in net cash from operating activities in Q1 2026, which supports dividend coverage and ongoing liquidity.
- Cash and securities remain large. Cash and due from banks totaled $22.7 billion, and trading account securities were $330.5 billion, giving MetLife significant financial flexibility.
- Retained earnings continue to build over time. Retained earnings increased to $45.1 billion from $43.1 billion a year earlier, suggesting the company has continued to accumulate profits.
- Revenue in Q1 2026 was driven mostly by non-interest income. Total revenue was $18.95 billion, led by premiums earned ($12.12 billion), capital gains ($4.76 billion), and service charges ($2.20 billion).
- Profitability was helped by investment gains. Realized and unrealized capital gains contributed meaningfully again, which can boost results but also adds earnings volatility.
- Separate account assets and liabilities are still very large. Both were $147.7 billion, indicating a sizable asset-management-style component that moves with market conditions.
- Share count was essentially unchanged in the latest quarter. Weighted average diluted shares were 643.4 million in Q1 2026, suggesting limited near-term dilution pressure.
- Quarterly earnings declined from the strong Q4 2025 level. Q1 2026 net income attributable to common shareholders fell to $1.14 billion from $778 million? More importantly, pretax income dropped to $1.51 billion from $1.12 billion and revenue fell from $24.05 billion to $18.95 billion, showing clear sequential pressure on the top and bottom lines.
- Cash flow was much weaker than the prior quarter. Operating cash flow fell to $2.69 billion from $7.08 billion in Q4 2025, while net change in cash turned negative at $(2.03) billion.
- Leverage remains high. MetLife had $39.6 billion of total debt in Q1 2026, including $33.0 billion of short-term debt, against only $27.3 billion of common equity.
- Book equity is still pressured by negative AOCI and treasury stock. Treasury stock was $(31.4) billion and AOCI was $(19.2) billion, both of which reduce reported equity and reflect ongoing market-related adjustments.
- Claims expense remains a major swing factor. Property and liability insurance claims were $13.54 billion in Q1 2026, making underwriting profitability sensitive to loss trends and catastrophe experience.
Longer-term trend: Compared with 2023 and 2024, MetLife’s business has remained broadly profitable, but quarterly earnings have become less consistent. Revenue and premiums have generally held up, yet results are increasingly dependent on investment gains, claims experience, and financing items. The balance sheet is still massive and liquid, but debt levels and volatile cash movements suggest investors should watch leverage, operating cash flow, and the stability of insurance margins closely.
06/15/26 09:32 PM ETAI Generated. May Contain Errors.